All Emerging Market articles – Page 37
-
White papersCoronavirus – weekly update – 20 May 2020
Exists from lockdown proceed with no major mishaps, leading the stock markets to still trade sideways. Progress towards implementing budget support is slow, which constitutes a potential risk and a source of volatility.
-
White papersGemologist: can we adapt to the new climate normal?
Climate change will test our ability to avoid mortal danger more than ever before. Humanity’s ability to adapt, something we have excelled at, must again come to the fore.
-
White papersGlobal Emerging Markets: ESG Materiality, Q2 2020
Welcome to the Global Emerging Markets’ ESG Materiality commentary – a quarterly publication that demonstrates our engagement activity with portfolio companies and showcases holdings that are creating positive impact aligned to the Sustainable Development Goals. In addition, we explore an environmental, social and governance (ESG) theme and its implications for the asset class.
-
White papersMarket Risk Insights: portfolio triage
In the Q2 2020 issue of Market Risk Insights, we provide our latest analysis of six key risk factors – volatility, correlation, stretch, liquidity, event and environmental, social and governance (ESG) – in order to help investors navigate the coronavirus sell-off.
-
-
White papersEmerging Markets Charts & Views - Market dislocation creating long-term opportunities
Two major drivers are shaping the landscape for EM countries: Covid-19 and oil dynamics. We are mindful that current events will have very significant negative effects on the economic outlook for EM this year, leading many countries into recession.
-
White papersECB QE Monitor - April 2020
ECB programs: €1,110bn of purchasing power in 2020, or around €110bn / month by the end of the year.
-
White papersAsset Class Return Forecasts - Q2 - 2020
In our latest analysis released at the beginning of the year, we had laid out our medium-term outlook as a correction of the business cycle, including an economic slowdown, yield curve inversion, a return to lower bound policy rates, and subdued inflation prints. The global shocks resulting from the eruption of the coronavirus pandemic have significantly altered the sequence of economic and financial phases, shortened the timeframe and expanded the scale of the ripple effect.
-
White papersMarket weekly – Riding the digital transformation with US equities
Lockdowns around the world have boosted the uptake of new technologies, speeding us into an even more digital-centric future. US equity markets offer investors access to such disruptive technology. To hear more about the opportunities, Daniel Morris, our senior investment strategist, catches up with Pam Hegarty, senior portfolio manager and equity analyst for US equities in our Boston office.
-
White papersThe day after #3 - ESG Resilience During the Covid Crisis: Is Green the New Gold?
Without a doubt, the coronavirus is shaking the financial industry like never before. This is not the first time the world has faced a pandemic of this scale, nor is the first time that policy makers, business leaders and pundits have asked: “Is it different this time around? Are we at a turning point?”
-
White papersThe Stock Market Is Not the Economy
COVID-19 has damaged a lot of things, including the link between the S&P 500 and the U.S. economy.
-
White papersMarket Commentary - Swoosh Recovery vs. Liquidity Splash
The exit from the lockdowns is proceeding cautiously. If anything the number of new cases globally has picked up over the past week, flirting with 100k on 15 May, the highest since 16 April (see our latest Facts and Figures, including new modelling). Scientists keep warning about the risk of relaxing social distancing too quickly. In the meantime the global economy struggles – we slightly cut our 2020 global growth forecast from -3.5% to -4%. The risks are skewed to the downside. The WHO reiterated concerns about a deadlier second wave this autumn and winter.
-
Asset Manager NewsGlobal Sustainable Outcomes - News & Views Q1 2020
This quarter has marked the end of the longest bull market in history after a decade-long recovery since the global financial crisis. Entering 2020, nobody would have predicted the “black swan” event that was to come, providing a lethal shot to both the financial markets and global economies.
-
Asset Manager NewsPharmaceutical companies in a golden age for drug discovery
As new technologies such as genomics spur development of innovative drugs, European pharmaceuticals companies stand out as high-quality, defensive growth stocks
-
Asset Manager NewsEurope’s manufacturers are in good shape for a downturn
After reorganising themselves over the past 10 years, many European manufacturers have more flexible business models with higher returns
-
Asset Manager NewsCovid-19: a pandemic with no precedent in a modern economy
The good-news stories and optimism of three months ago have been consigned to the bin, as the virus, lockdowns and economic bailouts take centre stage.
-
White papersCorporate Responsibility | A Moment of Truth
Pushed to its very limits, mankind reveals its true nature. As the health, economic and market crisis unfolds, and at a time when maximizing profits and shareholder returns is no longer the priority, the sincerity of corporate responsibility is being put to test.
-
White papersGlobal Supply & Demand Curves Shift to the Left
U.S. inflation came in soft for April amid low oil prices and weak global demand. The employment report saw leisure and hospitality with the highest job losses, and Saudi Arabia announced plans to cut oil production again, easing concerns over storage capacity limits worldwide.
-
White papersCOVID-19 Science and Economics
In the second installment of our COVID-19 series, we discusses the scientific and economic implications of the path to recovery with research analyst Camilla Oxhamre Cruse, who has a Ph.D. in medicine and M.Sc. in biochemistry, and global strategist Olga Bitel.
-
White papersWhat We Can Learn from China’s Rapid Normalization
China is further along the coronavirus curve than much of the rest of the world and is on a fast path toward normal. We think its experience bears close watching—not only because China is a major contributor to global economic activity, but also because there will likely be important takeaways for the rest of the world as other countries plan their own reopenings.
